The finance was raised via a private placement with Sun Life Investment Management.
The College says it chose to finance via the private placement market due to the supportive buy and hold nature of the investor base, the strong demand within it for high quality higher education credits and the negotiated nature of the market.
In the top three of the QS world university rankings and with a strong financial performance history, the RVC’s £45 million senior unsecured note offering generated significant investor interest both within the UK and North America; with the offer four times over-subscribed, the RVC was able to take advantage of highly competitive long-term interest rates.
The secured funding will allow capital developments on both of the College's campuses.
Professor Stuart Reid, the RVC Principal, said: "I am absolutely delighted that we have secured this innovative blue chip financial backing in a deal which reflects our international reputation and leadership in the veterinary and biomedical sciences. We now look forward to investing in the next phase of capital development at the RVC, securing our position for years to come."
Candace Shaw, Head of Private Fixed Income, Sun Life Investment Management, said: "We are pleased to support the continued growth of the RVC, a specialised higher education institution with a renowned reputation both in the UK and internationally. The financing of the RVC represents a sound investment and aligns to Sun Life’s long-term investment objectives in this sector."
Kruuse has announced that it is to become the exclusive veterinary distributor in Europe for Kit4Cat, a globally patented hydrophobic sand for veterinary use.
Kit4Cat is a biodegradable sand with a natural non-toxic urine repelling coating which allows veterinary surgeons, veterinary nurses and cat owners to collect a urine sample for urinalysis without resorting to more invasive procedures. Kit4Cat is put in the cat's normal litter tray, whereupon it repels rather than absorbs the urine, allowing it to be collected with a pipette.
Andrew Groom, Managing Director, Kruuse UK Ltd., said: "This exciting agreement and product range further expands Kruuse's small animal product portfolio with its customers in Scandinavia, mainland Europe and the UK; increasing the already extensive range of feline products available to the veterinary practitioner."
Daniel Levitt, BA, MSM, CEO, Co-Founder & Board Member of Coastline Global, the makers of Kit4Cat, said: "This agreement will further expand our products presence within the veterinary industry, using Kruuse's strong relationships within veterinary practices, to promote less stressful ways of urine test collection prior to diagnosis and treatment of cats."
A bogus vet who pleaded guilty to a number animal cruelty and fraud offences is being sought by Humberside Police after he failed to appear at court for sentencing.
Jayson Paul Wells (pictured right), 30, of Driffield in the East Riding of Yorkshire, is wanted by detectives in Grimsby after he failed to appear at Grimsby Crown Court.
The RCVS assisted Humberside Police with its original investigation and is publicising its appeal to help locate Mr Wells. Police believe that he may be trading as a herdsman in Nottingham or Cornwall and are keen to establish whether he is currently in either location.
Mr Wells was arrested on 2 October 2013 and charged with the following offences:
Mr Wells pleaded guilty to all offences.
Anyone who is aware of his whereabouts is asked to call Humberside Police on 101 or call Crimestoppers anonymously on 0800 555 111.
Mark Bowen, Associate Professor at The University of Nottingham, has been appointed as President of the British Equine Veterinary Association (BEVA) for 2015/16.
Mark will take over the role from Andrew Harrison at the end of BEVA Congress on 12th September. Vicki Nicholls, Veterinary Assistant at Wright and Morten Vets, Cheshire becomes President Elect.
He said: "BEVA’s strengths lie in its members, who are committed to the welfare of the horse and the advancement of clinical practice. With new benefits for members, a new website, a new role for the BEVA Trust and the highest quality of education, BEVA is now an even more forceful and effective voice for the equine profession, both internally and externally.
"Whilst the profession attempts to shape its future for the next 15 years, we must continue to support the innovative individuals in the profession who look ‘outside the box’ and make sure that the future of our profession, the next generation of veterinary surgeons, does not become restricted by dogma and tradition; that they too can replicate the level of innovation seen in equine practice over the last 50 years.
"It is vital that we continue to strengthen our relationships with the British Horseracing Authority and contribute to the development of a funding body to replace the Horserace Betting Levy Board. Our relationship with the BVA, the regulation of allied professionals, the rescheduling of ketamine, the new EU animal health regulations and EU medicines regulations, even the role of Europe, are key areas where BEVA will make veterinary voices heard for the benefit of equine welfare.
"Lastly, employment and retention of veterinary graduates in the profession is a cause of concern to us all. Over the next year we will enhance the Internship Awareness Programme and provide support and mentoring for the younger members of the profession. BEVA council is full of individuals committed to working on your behalf and I am looking forward to working alongside them all for the benefit of us all."
The weekly sessions will offer practical guidance for veterinary surgeons and nurses about how they can manage chronic cases in line with guidelines issued by the Royal College of Veterinary Surgeons, the British Veterinary Association and the government.
Dechra’s Veterinary Technical Advisor Emily Casey BVM&S MRCVS will present the first webinar tackling Addison’s disease on Thursday April 2 from 1pm to 2pm and again from 7pm to 8pm. It will be available to watch again or download via the Dechra Academy.
It will include advice on how to stabilise patients and administer Zycortal while respecting government guidelines, including prioritisation of blood testing, use of telemedicine and provision of additional owner support. Each webinar represents one hour of CPD.
Dechra’s Technical Services Manager Jamie Walker said: “Since the outbreak of coronavirus began, we have received a large number of calls from practices wanting advice and guidance on how they should be managing chronic cases at this time.
"Our case management webinars will offer practical advice on a number of common small animal issues and aim to provide reassurance and support to veterinary professionals at this challenging time."
Further webinars will be held each Wednesday in April.
To register for the free webinars visit www.dechra.co.uk/events.
Sanofi-aventis has signed an agreement under which it will buy Merck & Co Ltd's 50% stake in Merial Limited for $4 billion cash, after which it will own Merial outright.
According to the Wall Street Journal, Merck is selling its stake in Merial to avoid concerns from antitrust regulators that its pending acquisition of Schering-Plough will make it too dominant.
Merck, sanofi-aventis and Schering-Plough have also announced another agreement under which sanofi-aventis will have the option to combine Merck's Intervet/Schering-Plough Animal Health business with Merial to form an animal health joint venture owned equally by Merck and sanofi-aventis.
I thought Merial-Intervet-Schering-Plough was a bit of a mouthful, but sanofi-aventis-Merial-Intervet/Schering-Plough? The receptionist is going to have her work cut out.
The review started with a series of focus groups amongst veterinary professionals across multiple sectors.
This was followed by an analysis of the information gleaned from the focus groups, additional stakeholder submissions, data from the College's Covid surveys, independent research studies and formal legal advice to formulate an online qualitative survey to gain the views and feedback of UK-based veterinary professionals.
In this final stage, the public consultation, all veterinary professionals, vet and vet nurse students, practice managers and all those who work in the veterinary practice team are invited to share the extent to which they agree (or disagree) with each element of the proposed new guidance on ‘under care’, their views on the requirements for a 24/7 follow-up service following a remote prescription and other safeguards, and their feedback on the proposed definition of limited-service providers.
There will also be a consultation with members of the animal-owning public, which will likely include questions asking for information about animal owner experiences with remote prescriptions, the perceived advantages and/or disadvantages of remote prescribing, and views on 24/7 care and how important a service this is to respondents.
Dr Melissa Donald MRCVS, RCVS President and former Chair of the Standards Committee, said: “The past two years have shown us that the veterinary professions are highly capable of adopting new ways of working.
"It also revealed that we can adapt our established ways of practice to better respond to shifts in public expectations and advancements in technology.
"However, it is our collective responsibility to ensure that any changes continue to allow us to provide safe and effective care for our patients, and meet the appropriate expectations of our clients.
“Whilst we recognise and reflect on the need for change, the proposed guidance seeks to protect animal health and welfare and maintain public trust by ensuring that decision-making remains firmly in the hands of individual veterinary surgeons, as to what they, in their professional judgement, consider appropriate in a specific situation.
“This consultation, then, while not a referendum on whether RCVS guidance on ‘under care’ and 24-hour emergency first-aid and pain relief should change – that decision having been made by Standards Committee and approved by Council based on the evidence gathered, including the views of the profession and objective evidence, and legal advice – is a crucial opportunity for veterinary colleagues to tell us whether we have got the draft guidance right, whether the proposed safeguards are sufficient, and whether there is anything we might have missed or should amend.”
www.rcvs.org.uk/undercare.
The BSAVA has announced that comic Michael McIntyre has joined the line up for Congress Party Night.
McIntyre will be joining comedian Fred MacAulay and ventriloquist Paul Zerdin
To register for BSAVA, click here.
Zoetis has launched a one-dose vial of Rispoval IntraNasal, in order to offer respiratory health protection in calves as soon as possible after birth without either waiting to batch them in groups or wasting unused vaccine in multi-dose packs.
To make ready for use, the vaccine is reconstituted by mixing a powder with sterile diluent. Once mixed, the licensed shelf life is two hours. This means any that is unused in multi-dose packs must be thrown away. By stocking a combination of one- and multi-dose packs, farmers can eliminate this.
The vaccine protects against two primary viral causes of pneumonia in young calves, BRSv and Pi3v1. Surveillance of blood samples from 2,145 calves with pneumonia signs found 78% exposed to BRSv, 81% to Pi3v2. The product licence allows use from nine days of age, with onset of immunity to BRSv and Pi3v after five and 10 days respectively. The licence also specifies a duration of immunity of 12 weeks.
Zoetis vet Carolyn Hogan says that viruses are the instigator of a majority of respiratory health problems: "Early-life protection also helps reduce the threat from opportunistic secondary bacterial infections, such as Pasteurella.
"Good respiratory health is essential to ensure calves develop to achieve their lifetime potential. But it's estimated that 67% of pneumonia cases occur in calves less than three months of age3.
"Whether suckled or reared, calves that don’t grow effectively in the early weeks are unlikely to catch up later. On both dairy and beef units, proactive management of the calf living space, nutrition and disease resilience is critical to maximise lifetime productivity, which is clearly so important under today's farm business economics.
More information about the benefits of managing respiratory health in calves is available at plantoproduce.co.uk.
Last year’s competition saw photographs span a range of subjects from across the UK and overseas, from a common basilisk in Costa Rica and cattle during a TB testing day on the island of Arran, to a meerkat undergoing a vasectomy and a veterinary podiatrist at work.
Small animal vet Mandy Knight’s photo 'Happy Gastrotomy' and mixed-practice vet Jen Rowland’s photo of rare and native North Ronaldsay and Dartmoor sheep grazing under the milky way in Northumberland took the top prizes in their respective categories.
In January this year, the BVA was also invited to showcase 22 of the most commended photographs at an exhibition in the Houses of Parliament, to give MPs and Peers an insight into the varied roles performed by veterinary surgeons today.
This year’s competition, which is open to all BVA members, seeks images that highlight the human-animal bond within a veterinary practice as well as photographs of pets or wildlife taken outside of the working environment. Submissions should promote responsible animal interaction as well positive animal health and welfare.
Photographs can be submitted under one of two categories:
Human-animal bond
All creatures great and small
An expert panel of judges from the veterinary and photography worlds will judge this year’s entries. For the first time, BVA members will get the chance to select their favourite entry for the Members’ Choice Award, which will be open to votes from 27 August to 10 September.
The winner in each category will receive a £250 John Lewis gift voucher and have their photographs displayed at BVA Members’ Day in September, at other BVA events and used in BVA communications.
BVA President John Fishwick said: "The photo competition has created quite a buzz within the veterinary community since it launched two years ago. I have been delighted and amazed by the sheer range, quantity and quality of photographs submitted by our members so far and look forward to this year’s submissions.
"We are all passionate about animal health and welfare, so the way we interact with and capture images of the animal world offers a unique perspective, one that we were proud to showcase to members of parliament earlier this year. Whether you enjoy taking photos on your phone or have all the latest photography equipment, I would encourage all my colleagues within the veterinary family to give it a go and get clicking."
The competition closes at midnight on 19 August. More details about the competition, including terms and conditions, can be found at the BVA Photo Competition page: https://www.bva.co.uk/news-campaigns-and-policy/bva-photo-competition/
The full gallery of BVA Veterinary photographer of the year competition entries from 2016 and 2017 can be seen at: https://www.flickr.com/photos/britishvets/albums/
Photo: 'Happy Enterotomy' © Mandy Knight. CC BY-SA 2.0.
The company points out that poisoning cases rise dramatically over Christmas, when food that is poisonous to dogs is more likely to be left out and owners are more relaxed (is that a euphemism, TVM?).
For that reason, the Emedog bumper pack contains 20 x 1ml single use vials - four times more than the regular pack and retails at £251.76 a saving of 10% compared to purchasing four regular packs.
Dosage is one vial injected subcutaneously per 10kg and vials have a three-year unopened shelf life, which should minise wastage.
Will Peel MRCVS, Product Manager at TVM UK said: "The number of poisoned animals seen by vets rises dramatically over the festive season so it’s vital that vets have enough product to see them through this time. The Emedog bumper pack will ensure that they are prepared for Christmas with the resources they need to deal with such cases."
The Emedog bumper pack is available from November 2019 from all veterinary wholesalers.
The webinars, which are free of charge, are:
The webinars join 'The gastrointestinal microbiome and its effects', which is already available for free viewing via The Webinar Vet.
Product Manager Kai Crawshaw said: “We’ve received excellent feedback on the webinars from those who have already viewed them through our Learning Alliance platform. We hope that by also making them available via The Webinar Vet, we will make them more easily accessible to a higher number of veterinary professionals keen to refresh their knowledge in these important areas.”
The Animalcare webinars can be viewed here: https://www.thewebinarvet.com/webinars/animalcare
Bordetella bronchiseptica is a clinically significant pathogen for canine infectious respiratory disease (CIRD), otherwise known as kennel cough, with 78.7% of dogs with acute respiratory signs testing positive for the bacteria1.
In the same study, 45.6% of clinically healthy dogs also tested positive for Bordetella bronchiseptica, illustrating that clinically healthy dogs can carry respiratory pathogens and could act as sources of infection for susceptible dogs1.
Administered via subcutaneous injection, Canigen Bb is an inactivated subunit vaccine which offers vets a new option when intra-nasal vaccination with a live aerosolised vaccine is not possible or preferred, for example when the dog is in contact with known immunocompromised individuals.
Licensed for use in dogs from 6 weeks of age, Canigen Bb extends protection against Bordetella bronchiseptica in dogs vaccinated with Canigen KC in the last 12 months for a further year with a single dose.
Canigen Bb is presented as a ready-to-use formula in a 10ml multi-dose bottle and can be stored at room temperature (2°C - 25°C) for up to 4 weeks once broached.
It can be administered concurrently (at the same time but separate injections) with Canigen DHP, Canigen DHPPi, Canigen Pi & Canigen Lepto 4.
Andrew Connolly, Marketing Director at Virbac, said: ‘It is our hope that Canigen Bb will increase the overall uptake of Bordetella bronchiseptica vaccination to provide increased protection against this widely prevalent and clinically significant disease’.
Reference
Medivet, the practice group which is to feature in the forthcoming Panorama documentary It shouldn't happen at a vets' (9pm, July 22nd), has issued a statement concerning the programme.
The statement, which can be read in full here, includes an interview with a Medivet client who was in turn interviewed for the documentary:
Sue, an RCVS and European Specialist in Veterinary Dermatalogy and Senior Vice President of the European Society of Dermatology, says the failure to prioritise pain relief is having a "profound effect on the quality of life of both dogs and clients."
Sue is urging vets to think about the impact that pain has on both the dog and owner in cases of OE: "Otitis externa is painful, it’s debilitating, and the degree of discomfort is often underestimated by both the veterinary surgeon and by the client."
Sue also says vets should not underestimate the owner’s concern about pain in their dog. Owners recognise the clinical signs associated with the pain of OE and determine treatment success by their dog recovering from these distressing symptoms.
To help manage the pain associated with OE, Sue recommends a multi-modal approach: "In addition to systemic pain relief, which is really important, a potent topical steroid is really useful to reduce the inflammation inside that dog’s ear, and make it much more comfortable."
Sue also highlights OE treatments which are able to coat the ear canal and stay there long enough to treat the pathogens and provide sustained pain relief: "When you put it into the ear, Osurnia Gel coats the lining of the external ear canal which gives prolonged contact with the lining of the canal to help treat the pathogens inside that dog’s ear."
Elanco says that despite Osurnia entering the market two years ago, some vets are still saving it for difficult cases. Sue said: "Too many vets use this [Osurnia] as a second-line drug and it should be used as a first-line product on the first occasion the dog comes through the door."
To watch the full series of videos and to find out more from Sue Paterson on treating otitis externa in dogs, visit: www.Osurnia.co.uk
At a hearing in April Dr Johnston had admitted all the charges against him, which related fraudulent claims for the treatment of animals, two of which were fictitious, where he arranged for the insurance claims to be diverted and paid into a personal bank account.
Dr Johnston had admitted all the charges against him as well as admitting that his conduct was dishonest and amounted to serious professional misconduct.
Committee Chair Paul Morris said: “The Committee has no hesitation in concluding that the respondent’s dishonest conduct will have severely undermined the confidence of the public in the veterinary profession and, further, that his conduct fell far short of the standards and conduct properly to be expected of a member of the veterinary profession.
"The Committee is satisfied that this conduct by the respondent brought the profession into disrepute.”
The proceedings were then adjourned to allow a psychiatric report and other mitigation to be prepared.
At its resumed hearing on earlier this month, the Committee considered what sanction to impose.
The Committee found that aggravating features of his misconduct were that it was premeditated, carefully planned and sophisticated in that it involved the creation of numerous and extensive false clinical records to support his fraudulent claims.
It also considered the fact that he implicated an innocent professional colleague who worked alongside him at the practice, that he abused the trust placed in him by clients, that the dishonest conduct was repeated and that it involved significant financial gain in excess of £13,200 to be further aggravating features of his conduct
In terms of mitigation, the Committee accepted that he had made early admissions regarding his conduct to his employer and the College and accepted responsibility.
The Committee also heard that he had made attempts at remediation involving repayments of some of the sums lost by the practice and insurers.
It also considered positive testimonials from family and professional colleagues and the fact that Dr Johnston had taken significant steps to deal with the gambling addiction that was at the root cause of his misconduct.
Having considered all the evidence, the Committee decided to postpone its decision on sanction for a period of 2 years on the condition that Dr Johnston agree to undertakings including refraining from any form of gambling, subjecting himself to a close regime of support and supervision, and repaying some of the sums he had defrauded.
Paul added: “In reaching this conclusion the Committee wishes to make it clear that it has taken an exceptional course in this case.
"Ordinarily conduct of the type covered by the charges which this respondent has accepted will merit the imposition of a sanction of removal from the Register or a period of suspension from the Register.
"In this instance the Committee has found it possible to take the course that it has because it is satisfied that the respondent was, at the time, suffering from a recognisable psychiatric compulsive addiction… and that the fraudulent attempts by the respondent to obtain funds with which to gamble would not have occurred but for this psychiatric condition.
“The Committee further considers that the undertakings offered by the respondent will serve to reduce the risk that he will relapse into gambling again, for his conduct will be closely monitored and he will accept continuing support and guidance from the organisations currently assisting him.
“The Committee is also satisfied of the requirements that neither animals nor the public will be put at risk by this proposed course of action; that the respondent has demonstrated insight into the seriousness of his misconduct and that there is currently no significant risk of repeat behaviour; that his practicing standards are not in need of improvement so long as he continues to fulfil his CPD obligations; that the undertakings offered are capable of being met, are appropriate and are measurable; that there is evidence that his underlying medical problem is being appropriately addressed, will be monitored and reported on; and that he has responded positively to the opportunities for support and counselling which have been offered to him.”
If Dr Johnston fails to comply with his undertakings the Committee will reconvene and consider the charges with the full range of sanctions at its disposal.
www.rcvs.org.uk/disciplinary
Stuart Jackson, from Carterton, Oxfordshire, and Austin Kirwan from Ormskirk, Lancashire are the first candidates to achieve the RCVS postgraduate Certificate in Advanced Veterinary Practice (CertAVP), since the change-over to a modular award system in November 2008.
Both vets were assessed for the award through Middlesex University, and will receive designated Certificates in Veterinary General Practice - CertAVP (Vet GP).
There are currently 400 veterinary surgeons signed up for Certificate modules and - as long as they maintain an annual enrolment with the RCVS - these candidates have up to ten years to complete the full qualification. Vets can pursue a broad-based general CertAVP, or by selecting specific modules and taking an overall assessment, gain a more focused, designated CertAVP. With either option, all the modules the vet passes are listed on the Certificate. Individual module assessments can also be taken and used to fulfil continuous professional development requirements.
Freda Andrews, Head of Education said: "We congratulate both of these veterinary surgeons on their success and hope that this marks the start of further modular postgraduate qualifications being awarded. The Certificate structure allows enrolled veterinary surgeons to take up to ten years to complete the qualification. To complete the assessments within two years, as these vets have done, is very challenging."
Stuart Jackson, Principal of the Jackson Veterinary Clinic in Oxfordshire, said: "I am proud to be one of the first to complete the new Certificate in Advanced Veterinary Practice. I initially decided to undertake the new course because it is the first, and long overdue, postgraduate qualification that specifically recognises general practice as an important part of our profession. Although some of the content is unfamiliar to some, the structure as a whole is well designed and provides a refreshing analysis of the everyday routine of being in practice. It has provided an increased understanding of both clients and staff and has resulted in a better and happier place to work."
More information about the CertAVP can be found at: www.rcvs.org.uk/modcerts.
The Vaccination Guidelines Group (VGG) of the World Small Animal Veterinary Association (WSAVA) has updated the Vaccination Guidelines it offers to veterinary surgeons.
The association says its Canine and Feline Vaccination Guidelines aim to provide globally applicable recommendations to help veterinary surgeons vaccinate in a standard and scientifically justified fashion.
The VGG has also updated the vaccination guidelines it offers to pet owners and breeders, as well as the series of fact sheets it has created on key global vaccine-preventable diseases of dogs and cats.
The original guidelines were published in 2007 as the WSAVA's initial response to the need for globally applicable recommendations on vaccination best practice. They were updated in 2010 and, since then, the VGG, which is supported exclusively by MSD Animal Health, has been focusing on issues relating to small companion animal infectious disease and veterinary education in Asia.
The 2015 release of the Canine and Feline Vaccination Guidelines is based on a new evidence-based classification system for vaccinology. It also includes a number of additional FAQs (110 in total). The guidelines for both vets and owners/breeders are available for free download at http://www.wsava.org/educational/vaccination-guidelines-group. Currently available in English, they are being translated into a number of languages.
Professor Michael Day, Chair of the VGG (pictured right), said: "The vaccination guidelines are one of the most frequently downloaded resources on the WSAVA's website and are gradually driving a change in vaccination practice throughout the world - a change which is set to have a major impact on day-to-day small animal practice.
"We are delighted to launch these updated versions both for veterinarians and for pet owners and breeders. We hope they will prove even more helpful and ensure that more small animals are vaccinated in a more scientifically-based, robust and safer fashion.
"We would like to thank MSD Animal Health which has been the sole sponsor of the VGG since its inception. Its support enables us to undertake our valuable work."
The campaign uses Pennies, the digital charitable giving system which invites you to make a small donation when you pay for something by debit or credit card.
For the last four years, Medivet clients have been invited to make a donation of 50p when paying their veterinary bill, and the millionth donation was made at Medivet 24 Hour Shrewsbury this week.
Medivet says the funds raised have played a crucial role in helping to protect the rhino - enabling Wilderness Foundation Africa's Forever Wild Rhino Protection Initiative to support these critically endangered species across a wide range of activities. This includes the treatment of poaching attack survivors plus the care and rehabilitation of orphaned baby rhinos.
In terms of prevention, thanks to Medivet client donations, two cold scent tracker dogs have been deployed – Ella and Ziggy – who work with anti-poaching units, while support has also been provided for intelligence-sharing amongst local law-enforcement agencies. Funds have additionally been deployed to help drive global awareness, provide community services as well as essential field-based veterinary equipment.
Dr John Smithers, Senior Partner and Project Co-ordinator for Medivet Saving the Rhino, said: "We could not be more grateful to our clients for all they have done to help the survival of this iconic species. Their incredible generosity - combined with the support of our colleagues and partners - has made a real difference in the fight against poaching and we want to thank our clients for every donation made."
In South Africa, the Medivet-supported efforts to reduce poaching are co-ordinated by Dr William Fowlds, a former Medivet employee, who added: "This is a truly remarkable milestone and we are overwhelmed by the kindness of Medivet and its clients. The money raised not only helps protect the rhinos but helps bring to justice those responsible for the destruction of these precious and innocent creatures."
Alison Hutchinson, CBE, CEO of Pennies said reaching 1m donations was a remarkable achievement: “Pennies is proud to support Medivet’s Saving the Rhino campaign, and it’s been so inspiring to see one million individual micro-donations made through the digital charity box over the past four years.
"From all at Pennies, thank you and congratulations to the Medivet team and their hugely generous clients for reaching this milestone, for challenging the rhino poaching crisis in South Africa, and proving that small change truly does add up to mean big things."
Three cheers from VetSurgeon.org, too. That's a big achievement by Medivet for an important cause.
Canaural contains fusidic acid, framycetin and nystatin for their antibacterial and antifungal effects against the most common organisms associated with otitis externa.
Fusidic acid has skin penetrating properties and is active against staphylococci and streptococci1. Framycetin is active against Gram negative species. Dechra says the combination of the two provides an enhanced antibacterial effect on the most common bacterial cause of canine otitis2.
Nystatin is active against malassezia and prednisolone helps to provide anti-inflammatory and anti-pruritic action.
Dechra Brand Manager Carol Morgan said: “The reintroduction of Canaural to the veterinary treatment market means that once again veterinarians have this reliable and effective treatment available to tackle one of the most common canine complaints.
"Canaural is a tried and tested product and a recent study showed that fusidic acid is highly efficacious against both methicillin sensitive and methicillin resistant strains of Staphylococcus pseudintermedius3. Canaural remains as relevant today as it has ever been."
Canaural comes in 15 ml and 25 ml bottle sizes and is now available in veterinary wholesalers.
References
Vetoquinol UK Ltd is launching a dedicated large animal/equine sales force on the 1st July.
The company says the move reflects the change in cattle and equine veterinary practice to become specialists.
Vetoquinol's large animal brands include: Marbocyl®, Sedalin®, Equistro®, Tolfine®, Pro Rumen and Locatim®.
The new team comprises:
The new sales team will be managed jointly by Hugh Gibson and Stuart Wade.
For further information or to make an appointment please contact your local Territory Manager direct or telephone 01280 825424
Daniel Calvo Carrasco, an RCVS specialist in Zoo and Wildlife Medicine and a European Specialist in Avian Medicine and Surgery, will be heading up the new service, which opens its doors to patients in January.
Daniel graduated from Universitat Autònoma de Barcelona in 2010. He began his career at first opinion practices in Birmingham and Wiltshire, where he developed his skills as a vet in small animals, while still having the chance to look after small furries from a local pet shop where he was based. He then completed an exotic animal medicine and zoological medicine internship, followed by two years of small animal and exotic practice in the UK.
In May 2016 he gained his RCVS CertAVP(ZooMed) and later that year he completed his European College Zoological Medicine Avian residency.
For the next two years, he worked at Great Western Exotics before joining the Wildfowl & Wetlands Trust in 2018, where he combined conservation work with managing and caring for its living collection.
Daniel said: “I’ve always had a passion for zoological medicine and caring for the more exotic mammals, birds, reptiles and amphibians, and I’m excited to be leading this new service at Southfields.
“I really enjoy all aspects of exotic, zoo and wildlife medicine and have a particularly keen interest in orthopaedics and advanced surgery in exotic species.
“I have treated all sorts of species in my time from parrots and lizards to wading birds such as the Spoon-billed Sandpiper, Aldabra tortoise, Hyacinth Macaw, Toucans, Seriemas and many birds of prey.”
Southfields hospital director Daniel Hogan said: “We are delighted to have recruited Daniel to lead this exciting addition to the services we offer.
“He is highly experienced and will lead our new exotic animal service, which is the first such service in the whole of the South East and will be available 24/7 to offer the best and most comprehensive zoo and wildlife care in the region.”
For more information, visit: https://www.southfields.co.uk/
Rexxolide contains 100 mg/ml of tulathromycin, which is widely used to treat BRD and SRD. It also has a single dose and low injection volume of 1 ml/40 kg BW, to make it more convenient.
Dechra says Rexxolide has an immune-modulating and anti-inflammatory action and offers equal viscosity and syringability as other products on the market1. It can be used for treatment and metaphylaxis of BRD and SRD and offers early-stage treatment for infectious pododermatitis.
Dechra’s Equine and Food Producing Animal Brand Manager, Emma Jennings said: “Launching Rexxolide into the market provides an alternative option to existing BRD, SRD and foot rot treatments for farm vets across the UK and Ireland.
"We support an integrated approach to the control of BRD, with good husbandry, early detection and correct therapy being vital tools in managing the multi-factorial condition."
Rexxolide is available in 50ml and 100ml vials. For more information visit www.dechra.co.uk.
The Society for Companion Animal Studies (SCAS) has launched a distance learning course aimed at veterinary professionals working with individuals and families facing pet bereavement.
Officially accredited by the British Veterinary Nursing Association (BVNA), the course considers many forms of bereavement including the loss of a pet through illness, disease, ageing, accidental trauma or enforced separation due to changes in the owner's personal circumstances.
SCAS says the 'Pet Loss Support in Veterinary Practice' course has been co-written by leading international experts in pet loss support and aims to provide the specialist knowledge and skills required by the entire veterinary practice team. It offers up-to-date, in-depth information on many aspects of pet loss, including euthanasia; specific guidelines for children and older people; after death body-care and effective communication skills. The course provides practical guidelines and tips on how to introduce pet loss support protocols into practice management and also looks at self-care for staff, offering useful suggestions on how to recognise and minimise possible signs of stress and burnout.
Elizabeth Ormerod BVMS MRCVS, Chairman of SCAS said: "We should not underestimate the potential effects of grief on people's mental health and well-being and as vets we need to recognise the impact of pet loss on our clients and support them more fully than we currently do. Failure to fully understand and support the human-companion animal bond also has an adverse impact on animal welfare, and a negative effect on the success of a veterinary practice. Fifteen percent of clients who are not supported following pet loss choose never to adopt another companion animal. Of those who do adopt again, there is generally an extended interval before adoption and the likelihood of registering the new pet at a different veterinary practice."
The 'Pet Loss Support in Veterinary Practice' course is delivered through a distance learning programme, and students can register at any point during the year. The course, which includes all materials (a workbook and CD), is currently available at the special introductory offer of £375. SCAS members and members of BVNA receive a discounted rate of £325. Upon successful completion, students will be awarded 45 hours of CPD learning. For more information contact SCAS on 01993 825539 or email pbsstraining@bluecross.org.uk
Ceva Animal Health has launched Feliway Friends, a new pheromone to help reduce tensions and conflicts in households with more than one cat.
The company highlights a 2014 survey which found that 44% of cat owning households have more than one cat, with nearly a third of those questioned stating that they had experienced fighting and aggression between pets in the household1.
Feliway Friends is a synthetic copy of the cat appeasing pheromone (CAP) naturally produced by nursing queens to support their kittens after birth. The company says this pheromone helps cats feel safe and secure, and maintains a harmonious bond between them.
Ceva says Feliway Friends is clinically proven to significantly decrease the intensity and frequency of signs of tension in households with more than one cat. According to another study, 84% of cat owners believed there was a significant improvement in how their cats got on after using the product2.
Feliway Friends and Feliway Classic can be used at the same time if the owner is experiencing conflicts alongside other stress-related behaviour problems such as urine marking, scratch marking and general anxiety.
Available as a 30-day diffuser and refill, Feliway Friends lasts for up to 30 days and covers an area of up to 70m2.
Claire Russell, Feliway product manager at Ceva Animal Health, said: "Inter-cat aggression is a major problem in multi-cat households, with many cats experiencing stress in the home due to sharing resources. Feliway Friends is a great support to encourage harmony in multi-cat homes. By introducing the cat appeasing pheromone and educating owners on resource management and how to create a cat friendly home, we can significantly improve feline relationships in our UK multi-cat homes.’’
Ceva Animal Health has launched a range of marketing materials to support the launch of the new product, including an eight-page pet owner leaflet and poster. Practices can also request an online toolkit which includes: images, website content, social media assets and articles to help educate clients facing aggression between household cats.
For information on FELIWAY visit www.feliway.com/uk.